Wells Fargo & Company Immunocore Holdings PLC Transaction History

Wells Fargo & Company

$507 Billion
Q3 2025

A detailed history of Wells Fargo & Company transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Wells Fargo & Company holds 83,681 shares of IMCR stock, worth $3.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

83,681

Previous 80,761 3.62%

Holding current value

$3.01 Million

Previous $2.53 Million 19.97%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$31.87 - $37.2 $93,060 - $108,624	2,920 Added 3.62%	83,681 $3.04 Million
Q2 2025 Aug 14, 2025	SELL	$24.53 - $38.65 $71,357 - $112,432	-2,909 Reduced 3.48%	80,761 $2.53 Million
Q1 2025 May 13, 2025	BUY	$28.21 - $33.0 $331,044 - $387,255	11,735 Added 16.31%	83,670 $2.48 Million
Q4 2024 Feb 12, 2025	SELL	$28.14 - $34.69 $312,916 - $385,752	-11,120 Reduced 13.39%	71,935 $2.12 Million
Q3 2024 Nov 13, 2024	BUY	$30.06 - $41.49 $38,266 - $52,816	1,273 Added 1.56%	83,055 $2.59 Million

Q2 2024 Aug 13, 2024	SELL	$33.78 - $63.75 $145,726 - $275,017	-4,314 Reduced 5.01%	81,782 $2.77 Million
Q1 2024 May 10, 2024	BUY	$60.14 - $75.36 $117,453 - $147,178	1,953 Added 2.32%	86,096 $5.6 Million
Q4 2023 Feb 09, 2024	BUY	$42.85 - $69.5 $586,959 - $952,011	13,698 Added 19.44%	84,143 $5.75 Million
Q3 2023 Nov 13, 2023	BUY	$49.5 - $66.6 $852,142 - $1.15 Million	17,215 Added 32.34%	70,445 $3.66 Million
Q2 2023 Aug 15, 2023	BUY	$48.54 - $61.64 $2.56 Million - $3.26 Million	52,834 Added 13341.92%	53,230 $3.19 Million
Q1 2023 May 12, 2023	SELL	$46.12 - $65.71 $19,877 - $28,321	-431 Reduced 52.12%	396 $19,000
Q4 2022 Feb 13, 2023	BUY	$45.51 - $65.08 $17,794 - $25,446	391 Added 89.68%	827 $47,000
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $16,280 - $25,043	436 New	436 $20,000

Others Institutions Holding IMCR

# of Institutions

146

Shares Held

46.9M

Call Options Held

325K

Put Options Held

1.74M

View Full List

About Immunocore Holdings plc

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.58B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

More about IMCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Immunocore Holdings PLC Transaction History